COMPANY PROFILE

公司簡介
Jilin Zhengye Biological Products Co.,Ltd(stock No.:835605),be located in Jilin city of CHINA.in the National-level Jilin economic and technological development Area.It is one of the first 28 veterinary biological products enterprises directly under the ministry of agriculture in China.In 2004,the company from state-owned JiLin province biological products factory(has 50 years of production history) transformed into a private joint-stock enterprise, controlled by JiLin ZhengYe group. Mainly engaged in the production, R&D and sales of animal biological products and diagnostic reagents, etc. The company is a member of the standing council of China animal husbandry and veterinary society and a member of the Chinese veterinary medicine association, and has passed the GMP certification for three times in a row. Won the title of national high-tech enterprise twice, and was named Jilin city science and technology advanced unit, Jilin strategic emerging industries enterprise. In 2016, successfully listed on the NEEQ.
The registered capital of the company is RMB 65.60 million and the total assets value is 500 million yuan, the factory covers an area of 91.2 thousand square meters and the construction area is 35 thousand square meters, The total purification area is over 20,000 square meters. existing 14 GMP production line(Including suspended cell floating culture and genetic engineering production line),It adopts the advanced suspension culture technology and device of Germany SARTORIUS, as well as the automatic production line of automatic feeding and discharging, large capacity freeze-drying machine, bioreactor, washing and drying linkage and subpackage auto-line.
With 3000 square meters of animal experiment center and intelligent animal temperature measurement system, Simultaneous multi-animal testing and quality evaluation of vaccine products.
Annual comprehensive production of 18 billion doses/ml, had 35 animal vaccine production approval Numbers,covering swine, poultry, cattle, sheep, dog and other veterinary vaccine products.
The company has established long-term strategic cooperation and industry-university-research relations with IVDC, Harbin institute of veterinary medicine of the Chinese academy of agricultural sciences, Shanghai institute of veterinary medicine, institute of veterinary medicine of the military medical academy, jilin university, China agricultural university and jilin agricultural university.The research and development center of the company has a purification area of nearly 2000 square meters, and has been designated as jilin provincial technical center and academician workstation. Over the past ten years since its establishment, it has invested over 100 million yuan in research and development, and has been granted 18 national patents for invention and utility models. The products of the company have been sold to more than two dozen provinces and autonomous regions in the country, and many vaccine products have been listed by the government as designated purchase products.
Company's existing senior professional and technical titles 55 people, including: senior veterinarian, senior accountants, senior engineer, such as 25 people, the veterinarian, accountants, engineers, economists, intermediate professional and technical personnel 28 people, have a graduate degree or above personnel 20 people, and has a nearly 150 people, technical manager as the core, has 10 years of production experience and professional and technical workers to various kinds of vaccine production technology mature team.
Over the past decade, the company has been awarded the title of jilin advanced tax paying enterprise for many times, and has been awarded the title of jilin advanced scientific and technological unit and jilin strategic emerging industrial enterprise.Looking forward to the future, zhengye biotechnology will adhere to the mission of "science and technology make animals better", continuously improve customer value and customer experience, and in an era of VUCA, cooperate with customers for a win-win future.

COMPANY CULTURE

企業文化
Enterprise Mission

Technology for animals better

Enterprise spirit

HONEST AND TRUSTWORTHY, PRACTICAL INNOVATION,FORGE AHEAD IN UNITY,DEDICATION OF PATRIOTISM

core value

Being integrity person, walking on right way, doing right thing, revitalization of industry

Development orientation

SCIENCE AND TECHNOLOGY GIVE RISE TO HIGH-QUALITY,QUALITY ACHIEVEMENT ZHENGYE

GLORIES AND QUALIFICATION

榮譽資質


DEVELOPMENT PATH

發展歷程
1970年
農業部哈爾濱獸醫生物藥品廠部分搬遷至吉林市,成立吉林省獸藥廠
1987年
吉林省獸藥廠更名為吉林省生物制品廠,并獲得吉林省牧業局頒發的獸藥生產許可證
1996年
國內率先按照國際GMP標準的疫苗生產車間落成
1997年
按照國家標準率先落成2600平米的SPF雞舍一座
2004年
企業實行整體改制,吉林正業集團全資收購,成立吉林正業生物制品有限責任公司
2006年
公司首次通過國家農業部GMP驗收
2009年
公司以變更形式設立股份有限公司,企業類型由有限責任變更為股份公司
2011年
公司第二次通過國家農業部GMP驗收
2012年
公司建成2000平方米研發中心
2013年
公司首次通過國家高新技術企業認證
2015年
公司建成3000平方米動物實驗中心
2015年
公司研發中心并確定為省級技術中心和院士工作站
2016年

公司成功在全國中小企業股份轉讓系統掛牌

2016年

6月?公司第三次通過國家農業部GMP驗收

2016年

11月?公司第二次通過國家高新技術企業認證

2017年

9月?公司新建7700平米細胞懸浮培養車間落成, 使疫苗生產線由過去的8條,增加到14條,產能比過去提高三倍以上。

Friendship link:

Address:No. 1 Alliance Street, Economic and Technological Development Zone, Jilin City, Jilin Province Tel:0432-63047170
Ji ICP is prepared for No. 18003475 Login address

Copyright: Jilin Zhengye Biological Products company limited by shares
0432-63451777

top

腾讯广东麻将1.5.1版本